Submitted:
06 November 2023
Posted:
07 November 2023
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Patients and methods
2.1. Ethics
2.2. Statistical analysis
2.3. Antibodies, flowcytometry
3. Results
4. Discussion
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgements
Conflicts of Interest
Abbreviations
References
- O’keefe, S.J.; Buchman, A.L.; Fishbein, T.M.; Jeejeebhoy, K.N.; Jeppesen, P.B.; Shaffer, J. Short Bowel Syndrome and Intestinal Failure: Consensus Definitions and Overview. Clin. Gastroenterol. Hepatol. 2006, 4, 6–10. [Google Scholar] [CrossRef] [PubMed]
- Duro, D.; Kamin, D.; Duggan, C. Overview of Pediatric Short Bowel Syndrome. J. Pediatr. Gastroenterol. Nutr. 2008, 47, S33–S36. [Google Scholar] [CrossRef] [PubMed]
- Chandra, R.; Kesavan, A. Current treatment paradigms in pediatric short bowel syndrome. Clin. J. Gastroenterol. 2017, 11, 103–112. [Google Scholar] [CrossRef] [PubMed]
- Wershil, B.; Furuta, G. 4. Gastrointestinal mucosal immunity. J. Allergy Clin. Immunol. 2008, 121, S380–S383. [Google Scholar] [CrossRef] [PubMed]
- Ruth, M.R.; Field, C.J. The immune modifying effects of amino acids on gut-associated lymphoid tissue. J. Anim. Sci. Biotechnol. 2013, 4, 27–27. [Google Scholar] [CrossRef] [PubMed]
- Doe, W.F. The intestinal immune system. Gut 1989, 30, 1679–1685. [Google Scholar] [CrossRef] [PubMed]
- Duran, B. The effects of long-term total parenteral nutrition on gut mucosal immunity in children with short bowel syndrome: a systematic review. BMC Nurs. 2005, 4, 2. [Google Scholar] [CrossRef]
- Turato, W.M.; Sales-Campos, H.; Braga, C.B.M.; Cunha, S.F.C.; Silvah, J.H.; da Silva, J.S.; Marchini, J.S.; Cardoso, C.R.d.B. The impact of intestinal resection on the immune function of short bowel syndrome patients. Hum. Immunol. 2016, 77, 1202–1208. [Google Scholar] [CrossRef] [PubMed]
- Mandal, A.; Viswanathan, C. Natural killer cells: In health and disease. Hematol. Stem Cell Ther. 2015, 8, 47–55. [Google Scholar] [CrossRef]
- Orange, J.S. Natural killer cell deficiency. J. Allergy Clin. Immunol. 2013, 132, 515–525. [Google Scholar] [CrossRef] [PubMed]
- Conley, M.E.; Notarangelo, L.D.; Etzioni, A. Diagnostic Criteria for Primary Immunodeficiencies. Clin. Immunol. 1999, 93, 190–197. [Google Scholar] [CrossRef] [PubMed]
- Barrena, M.; Eizaguirre, I.; Aldazabal, P.; Cuadrado, E.; Bachiller, P.; Wang, W.; Tovar, J. Lymphocyte subpopulations after extensive small bowel resection in the rat. J. Pediatr. Surg. 1995, 30, 1447–1449. [Google Scholar] [CrossRef] [PubMed]
- Murakami, M.; Sato, N.; Sato, N.; Nakamura, T.; Masunaga, H. Changes in Lymphocyte Phenotypes and Cytokine Production by Surgical Stress in a Rat Small Intestinal Resection Model. J. Clin. Biochem. Nutr. 2007, 40, 216–220. [Google Scholar] [CrossRef] [PubMed]
- Lee, C.; Chen, J.; Li, M.; Chou, M.; Lo, H. Oral Antibiotics Attenuate Bowel Segment Reversal–Induced Alterations in Subpopulation and Function of Peripheral Blood Leukocytes, Thymocytes, and Splenocytes in Massive Bowel-Resected Rats. J. Parenter. Enter. Nutr. 2008, 33, 90–101. [Google Scholar] [CrossRef]
- Luckheeram, R.V.; Zhou, R.; Verma, A.D.; Xia, B. CD4+T Cells: Differentiation and Functions. J. Immunol. Res. 2012, 2012, 925135. [Google Scholar] [CrossRef]


| Age at evaluation ( months) |
Cause of bowel resection |
Anatomic part and length of resected bowel | Duration of total parenteral nutrition | Serum immunoglobulins IgM; IgA; IgG (g/l) |
|
| 1 | 101 | Gastroschisis | ileum, colon,140 cm | still ongoing | 1,06; 1,51; 10,3 |
| 2 | 87 | Intestinal atresia | jejunum, ileum, 120 cm | 6 years | 0,81; 0,55; 8,6 |
| 3 | 104 | Hirschsprung disease | ileum, colon, 110 cm | still ongoing | 0,72; 0,56; 9,22 |
| 4 | 72 | Gastroschisis | ileum, colon, 80 cm | 5 years | 0,4; 0,41; 5,78 |
| 5 | 103 | Intestinal atresia | ileum, colon, 90 cm | still ongoing | 0,54; 0,75; 12,5 |
| 6 | 8 | Necrotising enterocolitis | jejunum, 30 cm | 2 years | 0,22; 0,18; 4,91 |
| 7 | 31 | Intestinal atresia | ileum ,70 cm | 2 years | 0,4; 0,4; 5,67 |
| 8 | 20 | Intestinal atresia | jejunum, ileum, colon,130 cm | still ongoing | 0,33; 0,18; 5,03 |
| 9 | 22 | Necrotising enterocolitis | ileum 50 cm | still ongoing | 0,88; 0,18; 5,6 |
| 10 | 4 | Intestinal atresia | ileum, colon, 70 cm | still ongoing | 0,65; 0,36; 7,1 |
| 11 | 20 | Necrotising enterocolitis | jejunum, ileum, colon,90 cm | still ongoing | 0,8; 0,72; 5,1 |
| 12 | 127 | Gastroschisis | jejunum,50cm | 5 years | 0,33; 1,02; 13,75 |
| 13 | 124 | Intestinal atresia | ileum, colon,70 cm | 7 years | 0,51; 0,88; 10,75 |
| 14 | 31 | Intestinal atresia | jejunum, ileum,60 cm | still ongoing | 0,9; 0,72; 5,66 |
| 15 | 52 | Intestinal atresia | jejunum, ileum, 50 cm | 3 years | 0,44; 0,35; 7,64 |
| Subpopulation/unit | Patients with SBS ( N=15) |
Controls (N= 12) |
Statistical difference- p- value |
| lymphocytes G/mm3 | 3.73± 1.37 | 3.84±1.14 | 0,83 |
| T lymphocytes % | 71,66±4,8 | 63,85±5,85 | 0,03 |
| T lymphocytes G/mm3 | 2,70±1,02 | 2,43±0,70 | 0,53 |
| B lymphocytes % | 20,44±4,71 | 25,14±4,29 | 0,01 |
| B lymphocytes G/mm3 | 0.79± 0.40 | 0.99 ± 0.38 | 0,12 |
| CD4+ lymphocytes % | 42,33±7,72 | 39,21±7,72 | 0,24 |
| CD4+ lymphocytes G/mm3 | 1.63± 0.77 | 1.5± 0.53 | 0,81 |
| CD8+ lymphocytes % | 23,33±6,30 | 19,14±5,54 | 0,04 |
| CD8+ lymphocytes G/mm3 | 0.82± 0.29 | 0.73± 0.27 | 0,40 |
| NK lymphocytes % | 6,5±2,45 | 10,28±4,85 | 0,01 |
| NK lymphocytes G/mm3 | 0.24 ±0.11 | 0.39± 0.21 | 0,02 |
| CD4+/CD8+ | 2,07±1,07 | 2,23±0,76 | 0,38 |
| CD3+ activated lymphocytes % | 3,16±1,82 | 2,92±1,94 | 0,49 |
| CD3+ activated lymphocytes G/mm3 | 0.11±0.054 | 0.12±0.08 | 0,95 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).